Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11406550 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
Condition: Non Hodgkin Lymphoma
Interventions: Drug: Pegfilgrastim;   Drug: Filgrastim

Indicates status has not been verified in more than two years